furosemide has been researched along with Myocardial Ischemia in 8 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Magnesium depletion and hypomagnesemia are common among furosemide-treated patients with chronic congestive heart failure." | 7.70 | Metabolic and clinical effects of oral magnesium supplementation in furosemide-treated patients with severe congestive heart failure. ( Almoznino-Sarafian, D; Alon, I; Berman, S; Cohen, N; Golik, A; Gorelik, O; Modai, D; Weissgarten, J; Zaidenstein, R, 2000) |
| "The efficacy and side effects of the combination therapy of thiazide and furosemide administered to patients with refractory heart failure, for a prolonged period of time, were assessed." | 7.69 | Prolonged therapy by the combination of furosemide and thiazides in refractory heart failure and other fluid retaining conditions. ( Brif, I; Farfel, Z; Mayan, H; Mouallem, M, 1995) |
| "The effect of digoxin therapy on the survival of heart failure patients in sinus rhythm was assessed using a retrospective case control study." | 7.69 | Digoxin therapy and survival in heart failure in sinus rhythm. ( Banerjee, AK; Campbell, RW, 1996) |
| "Magnesium depletion and hypomagnesemia are common among furosemide-treated patients with chronic congestive heart failure." | 3.70 | Metabolic and clinical effects of oral magnesium supplementation in furosemide-treated patients with severe congestive heart failure. ( Almoznino-Sarafian, D; Alon, I; Berman, S; Cohen, N; Golik, A; Gorelik, O; Modai, D; Weissgarten, J; Zaidenstein, R, 2000) |
| "The efficacy and side effects of the combination therapy of thiazide and furosemide administered to patients with refractory heart failure, for a prolonged period of time, were assessed." | 3.69 | Prolonged therapy by the combination of furosemide and thiazides in refractory heart failure and other fluid retaining conditions. ( Brif, I; Farfel, Z; Mayan, H; Mouallem, M, 1995) |
| "The effect of digoxin therapy on the survival of heart failure patients in sinus rhythm was assessed using a retrospective case control study." | 3.69 | Digoxin therapy and survival in heart failure in sinus rhythm. ( Banerjee, AK; Campbell, RW, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okamoto, Y | 1 |
| Nohmi, T | 1 |
| Seki, K | 1 |
| Higa, Y | 1 |
| Strand, AO | 1 |
| Aung, TT | 1 |
| Agarwal, A | 1 |
| Freda, BJ | 1 |
| Slawsky, M | 1 |
| Mallidi, J | 1 |
| Braden, GL | 1 |
| Mouallem, M | 1 |
| Brif, I | 1 |
| Mayan, H | 1 |
| Farfel, Z | 1 |
| Richard, V | 1 |
| Ghaleh, B | 1 |
| Berdeaux, A | 1 |
| Giudicelli, JF | 1 |
| Banerjee, AK | 1 |
| Campbell, RW | 1 |
| Galatius, S | 1 |
| Wroblewski, H | 1 |
| Sørensen, VB | 1 |
| Bie, P | 1 |
| Parving, HH | 1 |
| Kastrup, J | 1 |
| Cohen, N | 1 |
| Alon, I | 1 |
| Almoznino-Sarafian, D | 1 |
| Zaidenstein, R | 1 |
| Weissgarten, J | 1 |
| Gorelik, O | 1 |
| Berman, S | 1 |
| Modai, D | 1 |
| Golik, A | 1 |
2 reviews available for furosemide and Myocardial Ischemia
| Article | Year |
|---|---|
[Planning of cardiothoracic surgery for chronic kidney disease patients].
Topics: Acute Kidney Injury; Aortic Aneurysm; Atrial Natriuretic Factor; Cardiopulmonary Bypass; Cardiovascu | 2013 |
Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics.
Topics: Arteriovenous Shunt, Surgical; Cardio-Renal Syndrome; Creatinine; Diuretics; Furosemide; Glomerular | 2011 |
6 other studies available for furosemide and Myocardial Ischemia
| Article | Year |
|---|---|
Not all ST-segment changes are myocardial injury: hypercalcaemia-induced ST-segment elevation.
Topics: Aged, 80 and over; Bone Density Conservation Agents; Brugada Syndrome; Cardiac Conduction System Dis | 2015 |
Prolonged therapy by the combination of furosemide and thiazides in refractory heart failure and other fluid retaining conditions.
Topics: Aged; Aged, 80 and over; Cardiomyopathy, Dilated; Chlorothiazide; Diuretics; Drug Administration Sch | 1995 |
Comparison of the effects of EXP3174, an angiotensin II antagonist and enalaprilat on myocardial infarct size in anaesthetized dogs.
Topics: Anesthesia; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Coronar | 1993 |
Digoxin therapy and survival in heart failure in sinus rhythm.
Topics: Administration, Oral; Aged; Cardiotonic Agents; Case-Control Studies; Digoxin; Diuretics; Drug Thera | 1996 |
Endothelin and von Willebrand factor as parameters of endothelial function in idiopathic dilated cardiomyopathy: different stimuli for release before and after heart transplantation?
Topics: Adult; Biomarkers; Cardiomyopathy, Dilated; Diuretics; Endothelin-1; Endothelium, Vascular; Female; | 1999 |
Metabolic and clinical effects of oral magnesium supplementation in furosemide-treated patients with severe congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Cardiomyopathy, Dilated; Citric Acid; Dietary Supplements; Diuret | 2000 |